• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

候诊患者:在基因组学时代,游走于疾病与健康之间。

Patients-in-waiting: Living between sickness and health in the genomics era.

机构信息

University of California-Los Angeles, Deparment of Sociology, 90095-1551, USA.

出版信息

J Health Soc Behav. 2010 Dec;51(4):408-23. doi: 10.1177/0022146510386794.

DOI:10.1177/0022146510386794
PMID:21131618
Abstract

What are the social consequences of the recent expansion of newborn screening in the United States? The adoption of new screening technologies has generated diagnostic uncertainty about the nature of screening targets, making it unclear not only whether a newborn will develop a disease but also what the condition actually is. Based on observations in a genetics clinic and in-depth interviews with parents and geneticists, we examine how parents and clinical staff work out the social significance of uncertain newborn screening results. We find that some newborns will experience a specific trajectory of prolonged liminality between a state of normal health and pathology. Based on a review of related literatures, we suggest "patients-in-waiting" as an umbrella concept for those under medical surveillance between health and disease.

摘要

最近美国新生儿筛查范围的扩大带来了哪些社会后果?新筛查技术的采用导致对筛查目标性质的诊断不确定性,不仅不清楚新生儿是否会患上疾病,甚至不清楚其具体情况是什么。基于遗传诊所的观察和对父母及遗传学家的深入访谈,我们研究了父母和临床工作人员如何确定不确定的新生儿筛查结果的社会意义。我们发现,一些新生儿将在正常健康和病理状态之间经历一种特定的、长时间的中间状态。通过对相关文献的回顾,我们提出“等待中的患者”作为介于健康和疾病之间的医学监测人群的一个总称。

相似文献

1
Patients-in-waiting: Living between sickness and health in the genomics era.候诊患者:在基因组学时代,游走于疾病与健康之间。
J Health Soc Behav. 2010 Dec;51(4):408-23. doi: 10.1177/0022146510386794.
2
Baby doe redux? The Department of Health and Human Services and the Born-Alive Infants Protection Act of 2002: a cautionary note on normative neonatal practice.“婴儿多伊”事件重演?美国卫生与公众服务部及2002年《出生时存活婴儿保护法》:关于规范新生儿医疗行为的警示
Pediatrics. 2005 Oct;116(4):e576-85. doi: 10.1542/peds.2005-1590.
3
Parents' experiences of newborn screening for genetic susceptibility to type 1 diabetes.父母对新生儿 1 型糖尿病遗传易感性筛查的体验。
J Med Ethics. 2011 Jun;37(6):348-53. doi: 10.1136/jme.2010.039206. Epub 2011 Jan 25.
4
Psychosocial risk associated with newborn screening for cystic fibrosis: parents' experience while awaiting the sweat-test appointment.与囊性纤维化新生儿筛查相关的社会心理风险:父母在等待汗试验预约期间的经历。
Pediatrics. 2005 Jun;115(6):1692-703. doi: 10.1542/peds.2004-0275.
5
Recommendations for effective newborn screening communication: results of focus groups with parents, providers, and experts.有效新生儿筛查沟通的建议:与家长、医护人员及专家的焦点小组讨论结果
Pediatrics. 2006 May;117(5 Pt 2):S326-40. doi: 10.1542/peds.2005-2633M.
6
Infant hearing screening: stakeholder recommendations for parent-centered communication.婴儿听力筛查:以家长为中心沟通的利益相关者建议
Pediatrics. 2006 May;117(5 Pt 2):S341-54. doi: 10.1542/peds.2005-2633N.
7
Medical technologies and the dream of the perfect newborn.医疗技术与完美新生儿之梦
Med Anthropol. 2011 Jan;30(1):56-80. doi: 10.1080/01459740.2010.531065.
8
Choosing not to choose: reproductive responses of parents of children with genetic conditions or impairments.选择不做选择:患有遗传疾病或缺陷儿童的父母的生育反应。
Sociol Health Illn. 2009 Jan;31(1):81-97. doi: 10.1111/j.1467-9566.2008.01110.x.
9
Ethical, legal and social issues in newborn screening in the United States.美国新生儿筛查中的伦理、法律和社会问题。
Southeast Asian J Trop Med Public Health. 2003;34 Suppl 3:52-8.
10
Parents' decision-making in newborn screening: opinions, choices, and information needs.父母在新生儿筛查中的决策:意见、选择和信息需求。
Pediatrics. 2010 Oct;126(4):696-704. doi: 10.1542/peds.2010-0217. Epub 2010 Sep 13.

引用本文的文献

1
The 2024 revisions of the McDonald criteria pose risk of multiple sclerosis overdiagnosis.2024年修订的麦克唐纳标准存在多发性硬化症过度诊断的风险。
Nat Rev Neurol. 2025 Sep 17. doi: 10.1038/s41582-025-01140-4.
2
Uncertainties in the NICU: a scoping review to inform a tailored taxonomy.新生儿重症监护室中的不确定性:一项用于构建定制分类法的范围综述
J Perinatol. 2025 Apr 16. doi: 10.1038/s41372-025-02299-w.
3
Development of an Online Scenario-Based Tool to Enable Research Participation and Public Engagement in Cystic Fibrosis Newborn Screening: Mixed Methods Study.
开发基于在线场景的工具以促进囊性纤维化新生儿筛查中的研究参与和公众参与:混合方法研究
J Particip Med. 2025 Mar 6;17:e59686. doi: 10.2196/59686.
4
Dietary Interventions for Breast Cancer Prevention: Exploring the Role of Nutrition in Primary and Tertiary Prevention Strategies.乳腺癌预防的饮食干预措施:探究营养在一级和三级预防策略中的作用
Healthcare (Basel). 2025 Feb 13;13(4):407. doi: 10.3390/healthcare13040407.
5
Parents' perceptions of the utility of genetic testing in the NICU.父母对新生儿重症监护病房基因检测效用的看法。
Genet Med. 2025 Feb 19;27(6):101393. doi: 10.1016/j.gim.2025.101393.
6
Newborn Screening for Gaucher Disease: Parental Stress and Psychological Burden.戈谢病新生儿筛查:父母的压力与心理负担
Int J Neonatal Screen. 2025 Feb 14;11(1):14. doi: 10.3390/ijns11010014.
7
Screening for Hearing Impairment in Newborns Using Targeted Genomic Sequencing: A Large Pilot Cohort Study.使用靶向基因组测序对新生儿听力障碍进行筛查:一项大型试点队列研究。
Clin Exp Otorhinolaryngol. 2025 May;18(2):152-161. doi: 10.21053/ceo.2024.00275. Epub 2025 Feb 14.
8
Genetic diagnosis of individuals at risk of CADASIL: prospect for future therapeutic development.对有患伴有皮质下梗死和白质脑病的常染色体显性遗传性脑动脉病(CADASIL)风险个体的基因诊断:未来治疗发展前景
J Neurol. 2024 Oct;271(10):6912-6922. doi: 10.1007/s00415-024-12640-6. Epub 2024 Sep 13.
9
Benefits and harms of antenatal and newborn screening programmes in health economic assessments: the VALENTIA systematic review and qualitative investigation.产前和新生儿筛查计划在健康经济评估中的获益和危害:VALENTIA 系统评价和定性研究。
Health Technol Assess. 2024 Jun;28(25):1-180. doi: 10.3310/PYTK6591.
10
Illness Narratives Without the Illness: Biomedical HIV Prevention Narratives from East Africa.《没有疾病的疾病叙事:来自东非的生物医学 HIV 预防叙事》。
J Med Humanit. 2024 Dec;45(4):345-368. doi: 10.1007/s10912-024-09862-0. Epub 2024 Jun 26.